H3-3B: A Promising Drug Target / Biomarker (G3021)
H3-3B: A Promising Drug Target / Biomarker
H3-3B is a protein that is expressed in various tissues of the body, including the brain, heart, and blood vessels. It is a key regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. While the exact function of H3-3B is not yet fully understood, it is clear that it plays an important role in the regulation of cellular processes that are critical for human health and disease. As such, H3-3B has emerged as a promising drug target and potential biomarker for a variety of diseases.
The H3-3B protein is a member of the basic helix-loop (BHL) family, which includes a number of proteins that are involved in the regulation of DNA replication, transcription, and other cellular processes. These proteins typically consist of a core BHL domain, which is followed by one or more additional domains that provide specific functions. The BHL domain is a structural element that is common to many proteins that belong to the BHL family, and is responsible for the formation of a beta-sheet that provides stability and structural integrity to the protein.
While the exact function of H3-3B is not yet fully understood, it is clear that it plays an important role in the regulation of cellular processes that are critical for human health and disease. For example, H3-3B has been shown to be involved in the regulation of cell growth and differentiation, as well as the regulation of cell survival and the response to stress. It has also been implicated in the development and progression of a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
One of the key challenges in studying the function of H3-3B is its complex structure and the fact that it is expressed in a wide variety of tissues and cells. While it is possible to study the effects of small molecules on H3-3B, it can be difficult to determine with certainty how these effects are related to the complex cellular processes that are involved in the regulation of cellular behavior.
In addition to its potential as a drug target, H3-3B is also a potential biomarker for a variety of diseases. Because it is expressed in a wide variety of tissues and cells, it is possible to use it as a diagnostic or predictive marker for a variety of conditions. For example, H3-3B has been shown to be expressed in a number of cancer tissues and has been used as a biomarker for the diagnosis of cancer. It is also possible that H3-3B could be used as a biomarker for other diseases, such as neurodegenerative disorders and autoimmune disorders.
The study of H3-3B is an active area of research, and there is a growing interest in the potential of this protein as a drug target and biomarker. While more research is needed to fully understand the functions of H3-3B and its potential as a drug, it is clear that it plays an important role in the regulation of cellular processes that are critical for human health and disease.
Protein Name: H3.3 Histone B
Functions: Variant histone H3 which replaces conventional H3 in a wide range of nucleosomes in active genes. Constitutes the predominant form of histone H3 in non-dividing cells and is incorporated into chromatin independently of DNA synthesis. Deposited at sites of nucleosomal displacement throughout transcribed genes, suggesting that it represents an epigenetic imprint of transcriptionally active chromatin. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling
The "H3-3B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H3-3B comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
H3-4 | H3-5 | H3-7 | H3C1 | H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15 | H3C2 | H3C3 | H3C4 | H3C6 | H3C7 | H3C8 | H3P16 | H3P36 | H3P37 | H3P44 | H3P5 | H3P6 | H4C1 | H4C11 | H4C12 | H4C13 | H4C14 | H4C15 | H4C16 | H4C2 | H4C3 | H4C4 | H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA | HADHAP1 | HADHB | HAFML | HAGH | HAGHL | HAGLR | HAGLROS | HAL | HAMP | HAND1 | HAND2 | HAND2-AS1 | HAO1 | HAO2 | HAO2-IT1 | HAP1 | HAPLN1 | HAPLN2 | HAPLN3 | HAPLN4 | HAPSTR1 | HAR1A | HAR1B | HARBI1 | HARS1 | HARS2 | HAS1 | HAS2 | HAS2-AS1 | HAS3 | HASPIN | HAT1 | HAUS1 | HAUS1P1 | HAUS2 | HAUS3 | HAUS4 | HAUS5 | HAUS6 | HAUS7 | HAUS8 | HAVCR1 | HAVCR1P1 | HAVCR2 | HAX1 | HAX1P1 | HBA1 | HBA2 | HBAP1 | HBB | HBBP1
